Scurvy is still a thing in Canada

McMaster University researchers surveyed the data of patients of Hamilton's two hospital systems over nine years and found 52 with low Vitamin C levels. This included 13 patients who could be diagnosed as having scurvy, and an additional 39 who tested positive for scurvy but did not have documented symptoms.

January 20, 2020

First author Kayla Dadgar did the research as a medical student at McMaster

Scurvy, the debilitating condition remembered as a disease of pirates, is still found in Canada.

The disease, which is caused by a vitamin C deficiency, can result in bruising, weakness, anemia, gum disease, hemorrhage, tooth loss, and even death if undiagnosed and untreated.

McMaster University researchers surveyed the data of patients of Hamilton’s two hospital systems over nine years and found 52 with low Vitamin C levels. This included 13 patients who could be diagnosed as having scurvy, and an additional 39 who tested positive for scurvy but did not have documented symptoms.

Among those with scurvy, some were related to alcohol use disorder or to bariatric surgery but the majority were related to other causes of malnutrition such as persistent vomiting, purposeful dietary restrictions, mental illness, social isolation and dependence on others for food.

“Scurvy is seen as a disease irrelevant to the modern world, but it still exists, and clinicians caring for at-risk patients should be aware of it and know how to diagnose it,” said John Neary, associate professor of medicine at McMaster and the senior author of the study published this month in the Journal of General Internal Medicine.

First author Kayla Dadgar, who did the research as a medical student at McMaster, said: “Scurvy should be a ‘never event’ in a healthy society. That it still occurs in Canada in our time indicates that we are not supporting vulnerable people as we should.”

She is now an internal medicine resident at the University of Ottawa.

The patients with scurvy who were given Vitamin C had a rapid recovery of their symptoms.

The study had no external funding.

Marek Smieja smiles while standing outside on a bright day.

McMaster scientist Marek Smieja receives prestigious national award for infectious disease research 

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.
Toronto skyline enveloped in yellowish smog.

Everyday air pollution linked to poorer brain function, study finds

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.
Smiling Sheila Singh wearing a McMaster lab coat, looking over lab equipment.

New McMaster-made drug candidate shows promise as a brain cancer treatment 

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.